About this trial
To evaluate the immunological effectiveness of Hyaluronic acid as adjunction treatment to scaling and root planning and scaling and root planning alone.
Comparison between clinical measurement before and after treatment. Evaluate the level of IGF-1 in treated site as immunological marker if periodontal regeneration.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
systemically healthy.
at least 20 teeth and suffers from moderate <7mm to severe. >8mm.periodontitis with probing depth >5m and in the contralateral side.
ability to attend to the clinic in a regular manner.
Disqualifiers
allergy to HA.
Chronic disease.
orthodontic treatment.
Qat chewer and smokers.
Trial design
Parallel
Treatments tested in this trial
Hyaluronic acid
DrugGengigel syringe containing 1ml of 0.8% HA
scaling and root planning
Behavioralscaling and root planning using ultrasonic scaler
Treatment groups
Trial outcomes
Primary outcomes
Changes in Plaque Index
ranges from 0 to 3 score, where increasing in number indicates the worst case.
Changes in Gingival Index
Ranges from 0 to 3 stages, where increasing in number indicates the worst case.
Changes in Papillary Bleeding Index.
Ranges from 0 to 4 score, where increasing in number indicates the worst case
Periodontal Probing Depth
distance from the gingival margin to the base of the pocket
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: